1. |
Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial. N Engl J Med 1997;337:949-55.
|
2. |
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087-106.
|
3. |
Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000;18:1220-9.
|
4. |
Smith BD, Haffty BG, Wilson LD, Smith GL, Patel AN, Buchholz TA, et al. The future of radiation oncology in the United States from 2010 to 2020: Will supply keep pace with demand? J Clin Oncol 2010;28:5160-5.
|
5. |
Dessena M, Dessi M, Demontis B, Grosso LP, Porru S, Meleddu GF, et al. Exclusive intra-operative radiation therapy (IORT) for early stage breast cancer: Pilot study of feasibility. G Chir 2011;32:104-9.
|
6. |
Menard J, Campana F, Kirov KM, Bollet MA, Dendale R, Fournier-Bidoz N, et al. Radiotherapy for breast cancer and pacemaker. Cancer Radiother 2011;15:197-201.
|
7. |
Jereczek-Fossa BA, Santoro L, Colangione SP, Morselli L, Fodor C, Vischioni B, et al. Electronic portal imaging registration in breast cancer radiotherapy verification: Analysis of inter-observer agreement among different categories of health practitioners. Neoplasma 2013;60:302-8.
|
8. |
Alford SL, Prassas GN, Vogelesang CR, Leggett HJ, Hamilton CS. Adjuvant breast radiotherapy using a simultaneous integrated boost: Clinical and dosimetric perspectives. J Med Imaging Radiat Oncol 2013;57:222-9.
|
9. |
Jones JM, Ribeiro GG. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol 1989;40:204-8.
|
10. |
Khan FM, Gibbons JP. Khan's the Physics of Radiation Therapy. Minnesota, USA: Lippincott Williams & Wilkins; 2014.
|
11. |
Zablotska LB, Neugut AI. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer 2003;97:1404-11.
|
12. |
Rubino C, de Vathaire F, Shamsaldin A, Labbe M, Lê MG. Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 2003;89:840-6.
|
13. |
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
|
14. |
Berrington de Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, et al. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 2010;102:220-6.
|
15. |
Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Møller H, et al. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study. BMC Cancer 2007;7:9.
|
16. |
Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, et al. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2002;52:406-14.
|
17. |
Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005;97:419-24.
|
18. |
Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A, et al. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: Nationwide cohort study of 90 000 Swedish women. BMJ 2003;326:256-7.
|
19. |
Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 2010;76:S77-85.
|
20. |
Bouyeh KA, Shokrani P, Amouheidari AR, Roayaei M. Evaluation of different treatment planning of breast cancer patients to estimate complications probability of lung and heart. J Isfahan Med Sch. (In Press).
|
21. |
Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 2003;55:724-35.
|
22. |
Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 1985;8:S13-9.
|
23. |
Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 1989;16:1623-30.
|
24. |
Warkentin B, Stavrev P, Stavreva N, Field C, Fallone BG. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets. J Appl Clin Med Phys 2004;5:50-63.
|
25. |
Salem A, Mohamad I, Dayyat A, Kanaa'n H, Sarhan N, Roujob I, et al. Combined photon-electron beams in the treatment of the supraclavicular lymph nodes in breast cancer: A novel technique that achieves adequate coverage while reducing lung dose. Med Dosim 2015;40:210-7.
|
26. |
Prasad SC, Bedwinek JM, Gerber RL. Lung dose in electron beam therapy of chest wall. Acta Radiol Oncol 1983;22:91-5.
|
27. |
Tavakoli MB, Taheri H, Akhavan A. Evaluation of calculation errors of treatment planning system in dose distribution of electron beams of 3D-CRT inside the lung. J Isfahan Med Sch 2017;35:900-4.
|
28. |
Muren LP, Maurstad G, Hafslund R, Anker G, Dahl O. Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiother Oncol 2002;62:173-83.
|
29. |
Hurkmans CW, Cho BC, Damen E, Zijp L, Mijnheer BJ. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 2002;62:163-71.
|